Glioblastoma Archive - Seite 12 von 24 - IOZK

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

2014-09-19/in Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-25

Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis

2014-09-12/in Dendritic Cells, Glioblastoma, International Publications /von 2014-09-12 / PLoS ONE 2014;9(9):e107173

Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme

2014-08-27/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2014-08-27 / Biomed Res Int 2014;2014:386470

Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice

2014-08-05/in Dendritic Cells, Exosome, Glioblastoma, Hypernephroma, International Publications /von 2014-08-05 / Int. J. Cancer 2015 Feb;136(4):E74-84

Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).

2014-06-01/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3069)

A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.

2014-06-01/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2005)

Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.

2014-05-31/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2087)

Dendritic cell immunotherapy for glioblastoma

2014-05-21/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-21 / Expert Rev Anticancer Ther 2014 Jul;14(7):761-3

Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

2014-05-13/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-13 / J Immunother Cancer 2014;2:10

Immunotherapy for high-grade glioma

2014-05-01/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-01 / Future Oncol 2014 May;10(6):911-5